Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide

被引：0
|
作者：
Aseem Anand
Michael J. Morris
Steven M. Larson
David Minarik
Andreas Josefsson
John T. Helgstrand
Peter S. Oturai
Lars Edenbrandt
Martin Andreas Røder
Anders Bjartell
机构：
[1] Lund University,Department of Translational Medicine, Division of Urological Cancers
[2] Memorial Sloan Kettering Cancer Center,Department of Medicine
[3] Weil Cornell Medical College,Department of Radiology
[4] Memorial Sloan Kettering Cancer Center,Department of Radiation Physics, Skåne University Hospital
[5] Lund University,Department of Urology, Institute of Clinical Sciences
[6] Sahlgrenska Academy,Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet
[7] University of Copenhagen,Department of Clinical Physiology, Nuclear Medicine and PET
[8] Copenhagen University Hospital,Department of Nuclear Medicine
[9] Skåne University Hospital,Department of Urology
[10] Skåne University Hospital,undefined
来源：
EJNMMI Research | / 6卷
关键词：
Bone Scan Index (BSI); Imaging biomarker; Bone scan; Enzalutamide; Metastatic castration-resistant prostate cancer (mCRPC);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide
    Anand, Aseem
    Morris, Michael J.
    Larson, Steven M.
    Minarik, David
    Josefsson, Andreas
    Helgstrand, John T.
    Oturai, Peter S.
    Edenbrandt, Lars
    Roder, Martin Andreas
    Bjartell, Anders
    EJNMMI RESEARCH, 2016, 6
  • [2] Quantitative imaging by automated bone scan index (BSI) as a response biomarker in standard clinical care of patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide.
    Anand, Aseem
    Belal, Sarah Lindgren
    Reza, Mariana
    Edenbrandt, Lars
    Bjartell, Anders
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [3] Bone Scan Index: A Quantitative Treatment Response Biomarker for Castration-Resistant Metastatic Prostate Cancer
    Dennis, Elizabeth R.
    Jia, Xiaoyu
    Mezheritskiy, Irina S.
    Stephenson, Ryan D.
    Schoder, Heiko
    Fox, Josef J.
    Heller, Glenn
    Scher, Howard I.
    Larson, Steven M.
    Morris, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05) : 519 - 524
  • [4] Prognostic Value of Automated Bone Scan Index in Men With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide or Abiraterone Acetate
    Miyoshi, Yasuhide
    Uemura, Koichi
    Kawahara, Takashi
    Yoneyama, Shuko
    Hattori, Yusuke
    Teranishi, Jun-ichi
    Ohta, Jun-ichi
    Takebayashi, Shigeo
    Yokomizo, Yumiko
    Hayashi, Narihiko
    Yao, Masahiro
    Uemura, Hiroji
    CLINICAL GENITOURINARY CANCER, 2017, 15 (04) : 472 - 478
  • [5] Automated bone scan index as a quantitative imaging biomarker indicative of efficacy to enzalutamide in patients with metastatic castrate resistant prostate cancer (mCRPC).
    Anand, Aseem
    Morris, Michael J.
    Larson, Steven M.
    Ohlsson, Mattias
    Joseffson, Andreas
    Helgstrand, John Thomas
    Edenbrandt, Lars
    Oturai, Peter Sander
    Roeder, M. Andreas
    Bjartell, Anders
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [6] Automated bone scan index as an imaging biomarker in metastatic castration resistant prostate cancer (mCRPC) patients treated with radium-223.
    Anand, Aseem
    Daignault, Stephanie
    Nordquist, Luke T.
    Ramos, Jorge
    Jain, Rohit K.
    McDonald, Matthew
    Campbell, Gregory
    George, Saby
    Albany, Costantine
    Yu, Evan Y.
    Bjartell, Anders
    Alva, Ajjai Shivaram
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] Prognostic value of an automated bone scan index for men with metastatic castration-resistant prostate cancer treated with cabazitaxel
    Uemura, Koichi
    Miyoshi, Yasuhide
    Kawahara, Takashi
    Ryosuke, Jikuya
    Yamashita, Daisuke
    Yoneyama, Shuko
    Yokomizo, Yumiko
    Kobayashi, Kazuki
    Kishida, Takeshi
    Yao, Masahiro
    Uemura, Hiroji
    BMC CANCER, 2018, 18
  • [8] Prognostic value of an automated bone scan index for men with metastatic castration-resistant prostate cancer treated with cabazitaxel
    Koichi Uemura
    Yasuhide Miyoshi
    Takashi Kawahara
    Jikuya Ryosuke
    Daisuke Yamashita
    Shuko Yoneyama
    Yumiko Yokomizo
    Kazuki Kobayashi
    Takeshi Kishida
    Masahiro Yao
    Hiroji Uemura
    BMC Cancer, 18
  • [9] Serum γ-Glutamyltransferase as a Prognostic Biomarker in Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide
    Takemura, Kosuke
    Ito, Masaya
    Nakanishi, Yasukazu
    Kataoka, Madoka
    Sakamoto, Kazumasa
    Suzuki, Hiroaki
    Tobisu, Ken-ichi
    Koga, Fumitaka
    ANTICANCER RESEARCH, 2019, 39 (10) : 5773 - 5780
  • [10] Enzalutamide for patients with metastatic castration-resistant prostate cancer
    Ramadan, Wijdan H.
    Kabbara, Wissam K.
    Al Masri, Hiba S. Al Basiouni
    ONCOTARGETS AND THERAPY, 2015, 8 : 871 - 876
12345